Trial Profile
Open, randomized study comparing the efficacy of retreatment with etanercept or rituximab, after failure of efficacy of rituximab in patients with active rheumatoid arthritis.
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 03 Jul 2012
Price :
$35
*
At a glance
- Drugs Etanercept (Primary) ; Methotrexate; Rituximab
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 29 Mar 2012 Planned End Date changed to 31 Mar 2012.
- 02 Jun 2011 New trial record